Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

A loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by Buffy.

M'Angale PG, Staveley BE.

BMC Res Notes. 2017 Jun 12;10(1):205. doi: 10.1186/s13104-017-2526-8.

2.

Bax-inhibitor-1 knockdown phenotypes are suppressed by Buffy and exacerbate degeneration in a Drosophila model of Parkinson disease.

M'Angale PG, Staveley BE.

PeerJ. 2017 Feb 21;5:e2974. doi: 10.7717/peerj.2974. eCollection 2017.

3.

Inhibition of mitochondrial calcium uptake 1 in Drosophila neurons.

M'Angale PG, Staveley BE.

Genet Mol Res. 2017 Feb 8;16(1). doi: 10.4238/gmr16019436.

PMID:
28198506
4.

Overexpression of Buffy enhances the loss of parkin and suppresses the loss of Pink1 phenotypes in Drosophila.

M'Angale PG, Staveley BE.

Genome. 2017 Mar;60(3):241-247. doi: 10.1139/gen-2016-0165. Epub 2016 Dec 22.

PMID:
28106473
5.

Knockdown of the putative Lifeguard homologue CG3814 in neurons of Drosophila melanogaster.

M'Angale PG, Staveley BE.

Genet Mol Res. 2016 Dec 19;15(4). doi: 10.4238/gmr15049290.

PMID:
28002605
6.

The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.

Merzetti EM, Dolomount LA, Staveley BE.

Genome. 2017 Jan;60(1):46-54. doi: 10.1139/gen-2016-0087. Epub 2016 Sep 15.

PMID:
27936908
7.
8.

The HtrA2 Drosophila model of Parkinson's disease is suppressed by the pro-survival Bcl-2 Buffy.

M'Angale PG, Staveley BE.

Genome. 2017 Jan;60(1):1-7. doi: 10.1139/gen-2016-0069. Epub 2016 Aug 30.

PMID:
27848260
9.

Identifying potential PARIS homologs in D. melanogaster.

Merzetti EM, Staveley BE.

Genet Mol Res. 2016 Nov 3;15(4). doi: 10.4238/gmr15048934.

PMID:
27819722
10.

Inhibition of Atg6 and Pi3K59F autophagy genes in neurons decreases lifespan and locomotor ability in Drosophila melanogaster.

M'Angale PG, Staveley BE.

Genet Mol Res. 2016 Oct 24;15(4). doi: 10.4238/gmr15048953.

PMID:
27813607
11.

Bcl-2 homologue Debcl enhances α-synuclein-induced phenotypes in Drosophila.

M'Angale PG, Staveley BE.

PeerJ. 2016 Sep 15;4:e2461. doi: 10.7717/peerj.2461. eCollection 2016.

12.

The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.

M'Angale PG, Staveley BE.

BMC Neurosci. 2016 May 18;17(1):24. doi: 10.1186/s12868-016-0261-z.

13.
14.

Extended longevity and survivorship during amino-acid starvation in a Drosophila Sir2 mutant heterozygote.

Slade JD, Staveley BE.

Genome. 2016 May;59(5):311-8. doi: 10.1139/gen-2015-0213. Epub 2016 Feb 22.

PMID:
27074822
15.
16.

Enhanced survival of Drosophila Akt1 hypomorphs during amino-acid starvation requires foxo.

Slade JD, Staveley BE.

Genome. 2016 Feb;59(2):87-93. doi: 10.1139/gen-2015-0113. Epub 2015 Nov 20.

PMID:
26783834
17.

Arm-Gal4 inheritance influences development and lifespan in Drosophila melanogaster.

Slade FA, Staveley BE.

Genet Mol Res. 2015 Oct 19;14(4):12788-96. doi: 10.4238/2015.October.19.22.

18.

spargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster.

Merzetti EM, Staveley BE.

BMC Neurosci. 2015 Oct 26;16:70. doi: 10.1186/s12868-015-0210-2.

19.

Compensatory growth in novel Drosophila Akt1 mutants.

Slade JD, Staveley BE.

BMC Res Notes. 2015 Mar 11;8:77. doi: 10.1186/s13104-015-1032-0.

20.

Expression of Pink1 with α-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan.

Todd AM, Staveley BE.

Genet Mol Res. 2012 May 21;11(2):1497-502. doi: 10.4238/2012.May.21.6.

21.

Expression of GFP can influence aging and climbing ability in Drosophila.

Mawhinney RM, Staveley BE.

Genet Mol Res. 2011 Mar 22;10(1):494-505. doi: 10.4238/vol10-1gmr1023.

22.

Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.

Todd AM, Staveley BE.

Genome. 2008 Dec;51(12):1040-6. doi: 10.1139/G08-085.

PMID:
19088817
23.

Huntingtin interacting protein 1 can regulate neurogenesis in Drosophila.

Moores JN, Roy S, Nicholson DW, Staveley BE.

Eur J Neurosci. 2008 Aug;28(3):599-609. doi: 10.1111/j.1460-9568.2008.06359.x.

PMID:
18702731
24.

foxo is required for resistance to amino acid starvation in Drosophila.

Kramer JM, Slade JD, Staveley BE.

Genome. 2008 Aug;51(8):668-72. doi: 10.1139/G08-047.

PMID:
18650956
25.
26.

Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.

Haywood AF, Staveley BE.

BMC Neurosci. 2004 Apr 16;5:14.

27.
28.

Expression of Drosophila FOXO regulates growth and can phenocopy starvation.

Kramer JM, Davidge JT, Lockyer JM, Staveley BE.

BMC Dev Biol. 2003 Jul 5;3:5. Epub 2003 Jul 5.

29.

Genetic analysis of protein kinase B (AKT) in Drosophila.

Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, Heitzler P, Woodgett JR, Manoukian AS.

Curr Biol. 1998 May 7;8(10):599-602.

30.

Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling.

Binari RC, Staveley BE, Johnson WA, Godavarti R, Sasisekharan R, Manoukian AS.

Development. 1997 Jul;124(13):2623-32.

31.
32.

Targeting of an enhancer trap to vestigial.

Staveley BE, Hodgetts RB, O'Keefe SL, Bell JB.

Dev Biol. 1994 Sep;165(1):290-3.

PMID:
8088446
33.

Genetic organization of the cSOD microregion of Drosophila melanogaster.

Staveley BE, Hilliker AJ, Phillips JP.

Genome. 1991 Apr;34(2):279-82.

PMID:
1905254
34.

Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster.

Staveley BE, Phillips JP, Hilliker AJ.

Genome. 1990 Dec;33(6):867-72.

PMID:
1964925

Supplemental Content

Loading ...
Support Center